Iriss Herbals Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -579.49%
- Ebitda 37.36%
- Net Worth -6.73%
- Total Assets -0.08%
About Iriss Herbals Lifesciences
Iriss Herbals Lifesciences Private Limited (IHLPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 August 2014 and has a history of Ten years and five months. Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Robert Cyril and Marina Cyrill serve as directors at the Company.
Company Details
-
Location
Kanpur Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74120UP2014PTC065615
-
Company No.
065615
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Aug 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Iriss Herbals Lifesciences Private Limited offer?
Iriss Herbals Lifesciences Private Limited offers a wide range of products and services, including Ayurvedic Medicine, Herbal Uterine Capsule Tablet, Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Herbal Capsules, Green Tea Capsules, Tea.
Who are the key members and board of directors at Iriss Herbals Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Robert Cyril
|
Director | 22-Aug-2014 | Current |
|
Marina Cyrill
|
Additional Director | 14-Aug-2020 | Current |
Financial Performance of Iriss Herbals Lifesciences.
Iriss Herbals Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 579.49% decrease in profit. The company's net worth dipped by a decrease of 6.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iriss Herbals Lifesciences?
Unlock access to Iriss Herbals Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Iriss Herbals Lifesciences?
Unlock and access historical data on people associated with Iriss Herbals Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iriss Herbals Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iriss Herbals Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
